Your right current treatment is awful so maybe Oncosil would be preferable.
As mentioned by Oncosil for Pancreatic Cancer
Poor prognosis -Median survival ~8 months and 5 year survival less than 7%
World market for pancreatic drugs is projected to exceed $1.2b by 2015
Current Chemo regime in excess of $60,000 per annum
High unmet medical need. • Pancreatic cancer has one year survival of 26%
Oncosil results to date for Pancreatic Cancer
Median overall survival was 309 days or 10+ months (compared with a typical 5.7 months with gemcitabine alone)
Potential Market Size (>105,000 pts p.a)
Total Market Opportunity for Oncosil in Pancreatic Cancer (>$1 Billion)
OSL Cash reserves to Q4 2016, Directors invested substantial amounts higher than current price.
- Forums
- ASX - By Stock
- OSL
- Impact of Sirflox failure to meet primary end point
Impact of Sirflox failure to meet primary end point, page-29
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.3¢ |
Change
0.001(4.17%) |
Mkt cap ! $47.30M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $3K | 240K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2672006 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 7772346 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 2672006 | 0.012 |
10 | 5311840 | 0.011 |
28 | 15945632 | 0.010 |
12 | 4961222 | 0.009 |
6 | 4596250 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 7772346 | 9 |
0.014 | 5914639 | 9 |
0.015 | 9160766 | 7 |
0.016 | 3766668 | 2 |
0.017 | 5088882 | 2 |
Last trade - 12.57pm 12/09/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |